Quarterly report [Sections 13 or 15(d)]

Other Income / (Expense)

v3.26.1
Other Income / (Expense)
9 Months Ended
Mar. 31, 2026
Notes to Financial Statements  
Other Income / (Expense)

Note 10. Other Income / (Expense):

The components of Other income (expense) in the accompanying Condensed Consolidated Statements of Earnings and Comprehensive Income are as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Quarter Ended

​

​

Nine Months Ended

​

​

March 31, 

​

​

March 31, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

​

2026

  ​ ​ ​

2025

Interest expense

​

$

(2,402)

​

$

(2,007)

​

$

(7,507)

​

$

(6,331)

Interest income

​

​

981

​

​

1,026

​

​

2,850

​

​

3,301

Gain (loss) on equity method investment

​

​

(739)

​

​

(589)

​

​

(335)

​

​

(169)

Other non-operating income (expense), net(1)

​

 

(2,110)

​

 

1,136

​

​

(2,622)

​

 

(1,594)

Total other income (expense)

​

$

(4,270)

​

$

(434)

​

$

(7,614)

​

$

(4,793)

(1) Fiscal 2026 primarily relates to the change in stock valuation for MDxHealth.